Skip to main content

JANUS HENDERSON GROUP PLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1274173 LONDON, X0

Position in DNLI

as of Mar 31, 2026 · filed May 18, 2026
Position Value
$1,152,537
+$161,475 QoQ
Shares Held
60,028
0.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANUS HENDERSON GROUP PLC holds $15,213,180,190 across 182 Biotechnology names. DNLI ranks #108 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,152,537 60,028
2025-12-31 $991,062 60,028
2025-09-30 $871,606 60,028
2025-06-30 $839,791 60,028
2025-03-31 $816,080 60,028
2024-12-31 $1,223,370 60,028
2024-09-30 $1,518,488 52,128
2024-06-30 $1,210,412 52,128
2024-03-31 $1,081,772 52,718
2023-12-31 $1,130,769 52,692
2023-09-30 $1,088,582 52,767
2023-06-30 $1,556,770 52,754
2023-03-31 $971,550 42,168
2022-12-31 $441,872 15,889
2022-09-30 $487,663 15,890
2022-06-30 $472,880 16,068
2022-03-31 $2,692,466 83,695
2021-12-31 $4,480,649 100,463
2021-09-30 $397,041 7,870